ScholarIQanswers from OpenAlex

Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age

PaperCitations, authors & open-access status

Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age have?

ScholarIQcitation count

Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age has 61 citations in the OpenAlex counts ScholarIQ stores.

When was Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age published?

ScholarIQyear

Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age has 2016 year in the ScholarIQ index.

What is the open-access status of Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age?

ScholarIQoa status

Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age has closed oa status in the ScholarIQ index.

What is the DOI of Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age?

ScholarIQdoi

The DOI for Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age is on the source record.

What is the PMID of Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age?

ScholarIQpmid

The PMID for Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age is on the source record.

What is the OpenAlex record for Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age?

ScholarIQopenalex

The OpenAlex for Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial